Application of the community dialogues method to identify ethical values and priorities related to pharmacogenomics
Given the expansion of genetics in medicine, there is a growing need to develop approaches to engage patients in understanding how genetics affects their health. Various qualitative methods have been applied to gain a deeper understanding of patient perspectives in topics related to genetics. Community dialogues (CD) are a bi-directional research method that invites community members to discuss a pertinent, challenging topic over the course of a multi-week period and the community members openly discuss their positions on the topic. Authors discuss the first application of the CD method to the topic of pharmacogenetics testing. Additional CD are needed to engage diverse participant populations on this topic to improve genetics literacy, enhance physician engagement and drive policy change.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Pharmacogenomics - 22(2021), 11 vom: 28. Juli, Seite 693-701 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Determeyer, Peggy [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bioethics |
|---|
| Anmerkungen: |
Date Completed 10.02.2022 Date Revised 10.02.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.2217/pgs-2021-0017 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM326628339 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM326628339 | ||
| 003 | DE-627 | ||
| 005 | 20231225195013.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2217/pgs-2021-0017 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1088.xml |
| 035 | |a (DE-627)NLM326628339 | ||
| 035 | |a (NLM)34114883 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Determeyer, Peggy |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of the community dialogues method to identify ethical values and priorities related to pharmacogenomics |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.02.2022 | ||
| 500 | |a Date Revised 10.02.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Given the expansion of genetics in medicine, there is a growing need to develop approaches to engage patients in understanding how genetics affects their health. Various qualitative methods have been applied to gain a deeper understanding of patient perspectives in topics related to genetics. Community dialogues (CD) are a bi-directional research method that invites community members to discuss a pertinent, challenging topic over the course of a multi-week period and the community members openly discuss their positions on the topic. Authors discuss the first application of the CD method to the topic of pharmacogenetics testing. Additional CD are needed to engage diverse participant populations on this topic to improve genetics literacy, enhance physician engagement and drive policy change | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a bioethics | |
| 650 | 4 | |a community dialogues | |
| 650 | 4 | |a patient-centered outcomes research | |
| 650 | 4 | |a personalized medicine | |
| 650 | 4 | |a pharmacogenetics testing | |
| 650 | 4 | |a pharmacogenomics | |
| 650 | 4 | |a precision medicine | |
| 650 | 4 | |a values | |
| 700 | 1 | |a Crowder, Jerome |e verfasserin |4 aut | |
| 700 | 1 | |a O'Mahony, Eimear |e verfasserin |4 aut | |
| 700 | 1 | |a Esquivel, Bernard |e verfasserin |4 aut | |
| 700 | 1 | |a Atwal, Herjot |e verfasserin |4 aut | |
| 700 | 1 | |a Atwal, Paldeep S |e verfasserin |4 aut | |
| 700 | 1 | |a Rogers, Sara L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacogenomics |d 2000 |g 22(2021), 11 vom: 28. Juli, Seite 693-701 |w (DE-627)NLM111671396 |x 1744-8042 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2021 |g number:11 |g day:28 |g month:07 |g pages:693-701 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2217/pgs-2021-0017 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2021 |e 11 |b 28 |c 07 |h 693-701 | ||